文献速递传染病防控与疫情报告免疫规划

I型菌毛CsuA/B与FimA联合免疫诱导针对鲍曼不动杆菌的保护性应答

Type I pili, CsuA/B and FimA induce a protective immune response against Acinetobacter baumannii.
PubMed 文献 · Vaccine · 2020-06-27

本研究在致死性与亚致死性小鼠脓毒症模型中,评估重组菌毛蛋白CsuA/B和FimA单独或联合主动免疫对鲍曼不动杆菌的保护效果。联合免疫在首次免疫后即产生高水平IgG,对致死剂量(1·2 × 10^6 CFU)攻击提供62%(5/8,p < 0·001)保护并促进脏器细菌清除;CsuA/B单独免疫部分保护(3/8,37%,p < 0·05),FimA单独免疫保护优于CsuA/B(4/8,50%,p < 0·01)。结果提示菌毛蛋白联合作为单一免疫原可能提供保护。

要点

  • CsuA/B与FimA联合免疫对致死剂量鲍曼不动杆菌攻击提供62%小鼠保护。
  • 联合免疫促进脾、肝、肺内细菌有效清除。
  • FimA单独免疫保护率50%,优于CsuA/B单独免疫的37%。

核心结论

  • 菌毛蛋白CsuA/B与FimA联合作为单一免疫原可对鲍曼不动杆菌感染提供保护。

研究设计与样本

  • 在小鼠致死性与亚致死性脓毒症模型中,评价重组CsuA/B和FimA单独或联合主动免疫的保护效果。

主要发现

  • 联合免疫在首次免疫后即产生高水平IgG,对致死剂量(1·2 × 10^6 CFU)攻击提供62%(5/8,p < 0·001)保护。
  • 联合免疫在亚致死攻击后促进脾、肝、肺内细菌有效清除。
  • CsuA/B单独免疫对致死攻击提供37%(3/8,p < 0·05)保护,亚致死感染后24小时脏器细菌减少。
  • FimA单独免疫对致死攻击提供50%(4/8,p < 0·01)保护,亚致死感染后14小时CFU减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acinetobacter baumannii, a nosocomial pathogen, is considered as a common cause of hospital and community-acquired infections. Emerging multidrug-resistance in this pathogen followed by subsequent problems in treatment has been increasing to alarming levels that warrant investigation of new therapeutic approaches. One strategy to reduce antibiotic resistance is to use of vaccines. Although there is no vaccine currently in development for this pathogen, different attempts have been made to develop one. METHODS: In this study, we used two different recombinant pilus proteins (CsuA/B and FimA) either singly or in combination to evaluate protective efficacy against A. baumannii in lethal and sub-lethal murine sepsis models. FINDINGS: Active immunization with recombinant proteins in combination elicited high levels of IgG antibody after the first immunization and provided 62% (five of eight mice; p < 0·001) protection against a lethal dose (1·2 × 106 CFU) of A. baumannii along with efficient clearance of bacteria in internal organs viz. spleen, liver, and lungs at sub-lethal challenge. Immunization with CsuA/B alone conferred partial protection as demonstrated by low survival rate (three [37%] of eight mice; p < 0·05) after lethal challenge and reduction of bacteria in internal organs of the mice after 24 h post-sub-lethal infection. Immunization with FimA, in comparison to CsuA/B, showed better protection (four [50%] of eight mice; p < 0·01) and reduction in CFU after 14 h. INTERPRETATION: Our results showed that pilus proteins in combination as a single immunogen could potentially impart protection against A. baumannii. FUNDING: Shahed University.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ramezanalizadeh F, Owlia P, Rasooli I, et al. Type I pili, CsuA/B and FimA induce a protective immune response against Acinetobacter baumannii. Vaccine. 2020. PMID: 32600914. doi:10.1016/j.vaccine.2020.06.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。